
The biotechnology, chemical, and pharmaceutical
technology groups at the U.S. Patent Office will hold their quarterly customer
partnership meeting on
June 13, 2007. The meeting can be attended either live at the PTO or via the
web. The topics listed on the agenda for the
day-long meeting include restriction between product and process inventions,
enablement issues in the examination of antibody inventions, RNAi patent space,
and guidance on routine optimization. Attendance space for the seminar is limited, and those interested in
attending can sign up here. Patent Docs will post highlights of
selected discussion topics following the seminar.

Patent Law Weblog
recent posts
- Why the Alice Test is Stupid, Part IV: The Usefulness Paradox
- Teva Capitulates to Federal Trade Commission Coercion
- USPTO Issues Memoranda on Subject Matter Eligibility
- USPTO Revokes Guidance on AI-Assisted Inventorship, But Rules Remain Basically the Same
- Why the Alice Test is Stupid, Part III: Eligible Independent Claims Can Have Ineligible Dependent Claims
about
Posted in Patent Office Rules & Procedures
Leave a comment